VedaBio
VedaBio is a provider of a molecular detection and editing platform using CRISPR Cascade technology. The platform offers near-instant molecular detection of multiplexed analytes without the need for target amplification, and can also be used for diagnostics, research, and therapeutic development. VedaBio leverages CRISPR-based technology to enable rapid, sensitive, and multiplexed molecular detection, transforming…
Funding snapshot
About
VedaBio is a provider of a molecular detection and editing platform using CRISPR Cascade technology. The platform offers near-instant molecular detection of multiplexed analytes without the need for target amplification, and can also be used for diagnostics, research, and therapeutic development. VedaBio leverages CRISPR-based technology to enable rapid, sensitive, and multiplexed molecular detection, transforming how diagnostics and research are conducted in genomics and molecular biology. Founded in 2021 and headquartered in San Diego, United States, VedaBio has raised approximately 40.1 million at the Series A stage with 26 employees and investors including OMX Ventures, Kleinmuntz Associates, Y Combinator, and Tao Capital Partners.
Business model
Genomics > Enabling Technologies > Technology Platforms > Genome Structure and Function
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.